Comerica Bank’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-50,870
Closed -$2.1M 2107
2015
Q2
$2.1M Buy
50,870
+25,993
+104% +$932K 0.01% 1487
2015
Q1
$877K Sell
24,877
-23,975
-49% -$811K 0.01% 1556
2014
Q4
$1.57M Buy
48,852
+23,699
+94% +$685K 0.01% 1581
2014
Q3
$706K Sell
25,153
-335
-1% -$10.2K 0.01% 1629
2014
Q2
$770K Sell
25,488
-1,140
-4% -$31.5K 0.01% 1622
2014
Q1
$737K Sell
26,628
-803
-3% -$21K 0.01% 1703
2013
Q4
$701K Sell
27,431
-1,155
-4% -$35.6K 0.01% 1731
2013
Q3
$855K Buy
28,586
+362
+1% +$10.1K 0.01% 1740
2013
Q2
$812K Buy
+28,224
New +$778K 0.01% 1507

Other funds holding BRLI

Comerica Bank's BRLI Position: Q3 2015 in Review

Comerica Bank sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 50,870 shares — an estimated $2.1M sold.

Comerica Bank first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $2.1M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Comerica Bank reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Comerica Bank sold 50,870 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $2.1M.
  • Comerica Bank first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Comerica Bank's BIO-REFERENCE LABS INC-NEW- position peaked at $2.1M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Comerica Bank's 13F filing for Q3 2015, filed 12 Nov 2015.